BioSpace News Archive

Hilburn previously served as Campaign Director at Light The Night, The Leukemia & Lymphoma Society’s nationally recognized funding campaign to build awareness of blood cancers.

Treatment of diffuse large B-cell lymphoma (DLBCL), primary mediastinal (thymus) large B-cell lymphoma (PMBCL), high-grade B-cell lymphoma (HGBL) and transformed follicular lymphoma (TFL), which are aggressive forms of non-Hodgkin lymphoma (NHL).

Innovative New Skincare Category Created by Bluemercury CEO and Co-Founder Marla Beck

Employees coast-to-coast will give back to their communities on October 12

Blue Health Intelligence (BHI®), one of the fastest-growing healthcare data and analytics firms, announced today it is collaborating with HM Health Solutions (HMHS), a leading provider of health payer solutions.

Today, the Canadian Life and Health Insurance Association (CLHIA) published its submission to the Government of Canada’s Advisory Council on the Implementation of National Pharmacare as part of its consultation process.

The Nora Roberts Foundation has donated $250,000 to Holy Cross Health to support the renovation and expansion of maternity and perinatal health services at Holy Cross Hospital, the largest birthing hospital in the state of Maryland and the District of Columbia.

Genetic testing company Seq2Know is now offering Celiac disease testing.

Karius, a life sciences company transforming infectious disease diagnostics with genomics, along with St. Jude Children’s Research Hospital, the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children, announced today at IDWeek™ 2018 the positive results of the pilot phase study of high-risk pediatric leukemia patients vulnerable to serious, life-threatening infections

Cue Biopharma, Inc. announced today that the Honorable Randall R. Rader has agreed to serve as the Chair of the company’s Intellectual Property Committee.